Abstract

Biohacking spans everything from harmless self-tracking to irreversible biological interventions, which is why it can look like either sensible self-care or reckless experimentation depending on where you draw the line. The biohacker’s dilemma is that the same user-led drive can expose unmet needs and accelerate clinically valuable innovation, but without guardrails, it can also normalise avoidable harm that later lands in clinics and emergency departments

Introduction

Shortlisted as Oxford’s Word of the Year for 2025, biohacking defines any process aimed at optimising physical or mental performance, health, and longevity. This includes tasks we consider mundane: tracking step count to hit fitness goals, or lifestyle trends such as mouth taping and cold plunges. As medical technology has advanced, a growing number of enthusiasts are moving into more ‘hardcore’ territory, aiming to use drugs, sensors, and even surgical implants to ‘hack’ human biology and enhance bodily function. Often ethically controversial, unregulated and potentially dangerous, extreme biohacking could still be a powerful upstream driver of clinical innovation if handled carefully. The ‘biohacker’s dilemma’ is the challenge of how to harness that user-led potential without legitimising unsafe self-experimentation. As consumer neurotech and DIY biology get cheaper and more accessible, the line between self-care and self-experimentation is blurring: when it goes wrong, the fallout lands in clinics and emergency departments.

The Tech-Biohacking Spectrum

Biohacking can broadly be classified as technologies that sense, modulate, or edit an individual’s health, with the most common examples designed for self-tracking. These include wearable devices such as smartwatches and rings, which allow individuals to turn metrics like heart rate, sleep, and blood glucose into actionable data to optimise their behaviour, usually with minimal risk. Where this becomes more complex is with modulation-based approaches. Here, users attempt to directly alter their physiology using tools such as DIY brain-stimulating headsets with transcranial direct current stimulation (tDCS) to enhance cognition, or Transcutaneous Electrical Nerve/Muscle Stimulation (TENS/EMS) devices for pain relief or muscular recovery. Some ‘biohackers’, often referred to as ‘grinders’, experiment with implantables, inserting magnets, LEDs, or RFID chips beneath their skin for convenience or for self-expression. For example, a US firm offered employees voluntary RFID implants to access doors and make purchases, a reminder that ‘implantable’ is often framed as convenience, not risk. At the end of this spectrum, a small number of extreme biohackers may use gene editing/gene therapy outside of regulated trials to modify their own DNA. The same label spans low-risk self-tracking and high-stakes self-experimentation, which is why debate around biohacking is so polarised.

How does Biohacking Drive MedTech Innovation?

Biohacking can highlight areas where medical technology has progressed too slowly. Most notable is the development of the artificial pancreas born from the ‘#WeAreNotWaiting’ movement, centred around the difficulty in sharing and using the data from continuous glucose monitors (CGMs) in the way families needed. This led to the creation of ‘Nightscout’, an open-source platform enabling CGM data to be monitored remotely, allowing caregivers to respond faster and in real time. Frustrated by the pace of industry, people with diabetes built their own ‘closed-loop’ systems by linking glucose monitors and insulin pumps via custom algorithms. This user-led innovation demonstrated tangible demand and real-world feasibility for devices that genuinely meet patient needs, paving the way for the regulated commercial systems used in precision metabolic care today. This is biohacking at its best: user-led design pressure that ultimately gets pulled into regulated care.

Why DIY Medicine is Dangerous

In contrast to sensing technologies, which are generally considered low-risk, interventions that modify physiology or involve implantation often come with significant risk. With at-home tDCS, individuals pass electrical current across targeted brain regions in the pursuit of cognitive enhancement (e.g., focus, memory, or creativity). In research and some clinical settings, tDCS is explored for neurological and psychiatric indications where potential benefit may justify risks. In healthy individuals without professional administration and supervision, the risks no doubt exceed any hypothesised benefit. Significant risks include unknown neurological changes resulting from unintended stimulation of adjacent brain regions, given the diffuse and unpredictable flow of current through neural tissue. 

Implantable chips marketed for convenience carry surgical risk, especially when inserted outside a clinical setting. The main issue is not usually the implant itself; it’s the lack of sterile technique, follow-up, and adverse-event reporting. Documented cases of persistent infection requiring surgical removal show how quickly a ‘small procedure’ can become a medical problem

At the far end of the spectrum are nonconventional genetic interventions, sometimes framed as gene therapy (adding genetic material) or gene editing (changing DNA), where irreversibility raises the stakes. The key difference isn’t just complexity, but persistence: if something goes wrong, you can’t simply stop wearing it or switch it off. That’s why regulated genetic medicine is paired with strict manufacturing standards, patient selection, monitoring, and long-term follow-up designed to catch delayed harms.

Beyond ethical concerns such as eugenics and bioterrorism, the biomedical risks are nontrivial: unintended genetic effects that may only emerge over time, potential cancer-related consequences depending on how DNA is altered or delivered, and immune-mediated toxicity from delivery platforms. Despite this, experimentation still occurs in small groups of biohackers. High-visibility examples include a ‘vaccine beer’ self-experiment using engineered yeast, alongside DIY attempts to alter traits like lactose tolerance and the wider availability of mail-order CRISPR kits that can normalise the idea that biology is plug-and-play. The dilemma is that the ambition isn’t always the issue; it’s the absence of the guardrails that make genetic interventions even remotely safe enough to justify

Media coverage often frames extreme biohackers as reckless or revolutionary, but the practical issue is simpler: without protocols and oversight, safety and efficacy are guesswork. 

Clinical Convergence

In comparison to DIY methods for biological enhancement, some companies have translated experimental concepts into regulated clinical devices. A prominent example is the development of implantable brain-computer interfaces by Neuralink and Synchron (endovascular systems), designed to restore function for individuals with severe paralysis, including after spinal cord injury, stroke, or motor neuron disease (ALS). These systems enable communication and device control. Crucially, they’re being developed first for severe disability, under oversight that forces careful patient selection, monitoring, and reporting. This demonstrates a concept with significant clinical promise, moving through regulated trials: the difference to some other biohacking innovations is not its ambition, but the guardrails in place to ensure safety, monitoring and accountability.

Conclusion: Stewardship over Skepticism

Biohacking is a messy driver of innovation. Rather than dismissing it as purely fringe or inherently harmful, the medical community should adopt an approach of ‘stewardship over scepticism’, as Lakhan frames it. This means building guardrails, such as clear risk communication, adverse event reporting systems, and structured evaluation pathways, while still nurturing the curiosity that drives progress. By engaging with the movement openly, we can ensure that the next wave of human enhancement unfolds with precision and accountability rather than in the shadows of a ‘home hack’. People will experiment; the question is whether the clinical world will help them do it wisely and safely.

Definitions:

• Biohacking: Any self-directed attempt to measure, modify, or optimise biology, ranging from low-risk self-tracking to high-stakes self-experimentation.
• Grinders: Biohackers who experiment with implantables (e.g., magnets, LEDs, RFID chips) for convenience, functionality, or self-expression.
• DIY medicine: Non-clinical use of medical-like tools or interventions (devices, implants, or biological ‘therapies’) without standard safeguards such as sterile technique, dosing protocols, monitoring, and adverse-event reporting.
• Guardrails: The safety infrastructure that makes innovation defensible and scalable: regulation, quality control, eligibility criteria, monitoring, and accountability (including adverse-event reporting).

References:

• Braune, K., Katarzyna Anna Gajewska, Axel Thieffry, Lewis, D., Froment, T., O’Donnell, S., Speight, J., Hendrieckx, C., Schipp, J., Skinner, T., Langstrup, H., Tappe, A., Raile, K. and Cleal, B. (2021). Why #WeAreNotWaiting—Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. Journal of Medical Internet Research, 23(6), pp.e25409–e25409. doi:https://doi.org/10.2196/25409.
• Gangadharbatla, H. (2020). Biohacking: An exploratory study to understand the factors influencing the adoption of embedded technologies within the human body. Heliyon, 6(5), p.e03931. doi:https://doi.org/10.1016/j.heliyon.2020.e03931.
• Gruber, K. (2019). Biohackers. EMBO reports, 20(6). doi:https://doi.org/10.15252/embr.201948397.
• Lakhan, S.E. (2025). The Evolution of Do-It-Yourself Brain Hacking: From Fringe to Frontier. Cureus. [online] doi:https://doi.org/10.7759/cureus.85330.